ArticleHaematologica2015
Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas.
Abstract readLetter
In one paragraph
Article in Haematologica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- T cell lymphomas: cancers of aberrant immune synapse signalling.Nature reviews. Immunology · 2026Review
- Insights into Nodal T-Follicular Helper Cell lymphomas and Peripheral T-Cell Lymphomas, Not Otherwise Specified, in Slovenian Patients: Mutational Landscape, Clinicopathological Characteristics, and Outcomes.Annals of hematology · 2025Article
- Heterozygous variants ineLife · 2025Article
- Binding of RHOA G17V to p300 enhances its HAT activity: a new mechanism of epigenetic deregulation in TFH lymphoma.Blood advances · 2025Article
- Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions.Haematologica · 2023Review
- Activation Mechanisms and Diverse Functions of Mammalian Phospholipase C.Biomolecules · 2023Review
- Primary pulmonary T-cell lymphoproliferative disorders with a limited-stage, low proliferative index, and unusual clinical behavior: two cases of a rare occurrence.Virchows Archiv : an international journal of pathology · 2023Article
- A Patient With CD20-positive T-cell Lymphoma Concurrently Exhibiting B-cell Neoplasm-related Genetic Abnormalities Shows Clonal Escape Post CD20-targeting Treatment.Annals of laboratory medicine · 2023Article
- Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.The British journal of dermatology · 2022Article
- Overarching roles of diacylglycerol signaling in cancer development and antitumor immunity.Science signaling · 2022Review
- Emerging roles of PLCγ1 in endothelial biology.Science signaling · 2021Review
- Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma.Blood advances · 2020Article
- Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma.Scientific reports · 2020Article
- Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma.PloS one · 2020Article
- Reduced PLCG1 expression is associated with inferior survival for myelodysplastic syndromes.Cancer medicine · 2020Article
- Genetic alterations affecting GTPases and T-cell receptor signaling in peripheral T-cell lymphomas.Small GTPases · 2019Review
- STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma.Oncotarget · 2018Article
- Article
- Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.Oncotarget · 2017Article
- Actionable mutations in canine hemangiosarcoma.PloS one · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Rebeca MansoPathology Department, IIS-Fundación Jiménez Díaz, UAM, Madrid, Spain.
Socorro M Rodríguez-PinillaPathology Department, IIS-Fundación Jiménez Díaz, UAM, Madrid, Spain.
Julia González-RincónGroup of Research in Lymphoma, (Medical Oncology Service), Oncohematology Area, IIS Puerta de Hierro-Majadahonda (IDIPHIM), Madrid, Spain.
Sagrario GómezGroup of Research in Lymphoma, (Medical Oncology Service), Oncohematology Area, IIS Puerta de Hierro-Majadahonda (IDIPHIM), Madrid, Spain.
Silvia MonsalvoHaematology Department, IIS-Fundación Jiménez Díaz, UAM, Madrid, Spain.
Pilar LlamasHaematology Department, IIS-Fundación Jiménez Díaz, UAM, Madrid, Spain.
Federico RojoPathology Department, IIS-Fundación Jiménez Díaz, UAM, Madrid, Spain.
David Pérez-CallejoGroup of Research in Lymphoma, (Medical Oncology Service), Oncohematology Area, IIS Puerta de Hierro-Majadahonda (IDIPHIM), Madrid, Spain.
Laura CerecedaPathology Department, Hospital U. Marqués de Valdecilla, IDIVAL, Santander, Spain.
Miguel A LimeresPathology Department, Hospital U. Canarias Dr. Negrín, Gran Canaria, Canarias, Spain.
Carmen MaesoPathology Department, CMI Nuestra Señora de la Candelaria, Sta. Cruz de Tenerife, Spain.
Lucía FerrandoPathology Department, Hospital San Pedro de Alcántara, Cáceres, Spain.
Carlos Pérez-SeoanePathology Department, Hospital Reina Sofía, Córdoba, Spain.
Guillermo RodríguezPathology Department, Hospital Reina Sofía, Córdoba, Spain.
José M ArrindaPathology Department, Hospital del Bidasoa, Guipúzcoa, Spain.
Federico García-BragadoPathology Department, Hospital Virgen del Camino, Pamplona, Spain.
Renato FrancoPathology Department, Istituto Nazionale Tumori IRCSS - Fondazione Pascal, Napoli, Italy.
José L Rodriguez-PeraltoPathology Department, Hospital U. 12 de octubre, Madrid, Spain.
Joaquin González-CarreróPathology Department, Complejo Hospitalario U. de Vigo, Pontevedra, Spain.
Francisco Martín-DávilaPathology Department, Hospital General de Ciudad Real, Spain.
Miguel A PirisPathology Department, Hospital U. Marqués de Valdecilla, IDIVAL, Santander, Spain.
Margarita Sánchez-BeatoGroup of Research in Lymphoma, (Medical Oncology Service), Oncohematology Area, IIS Puerta de Hierro-Majadahonda (IDIPHIM), Madrid, Spain msbeato@idiphim.org.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Antineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorFemaleFollow-Up StudiesHumansImmunoenzyme TechniquesLymphoma, T-Cell, PeripheralMaleMiddle AgedMutationNeoplasm StagingPhospholipase C gammaPrognosisSurvival RateTissue Array AnalysisBiomarkers, TumorPhospholipase C gammaPLCG1 protein, humanperipheral T-cell lymphomasPLCG1
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.